These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710 [Abstract] [Full Text] [Related]
8. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM. BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392 [Abstract] [Full Text] [Related]
9. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774 [Abstract] [Full Text] [Related]
10. Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome. Pepene CE. Clin Endocrinol (Oxf); 2012 Jan; 76(1):119-25. PubMed ID: 21740456 [Abstract] [Full Text] [Related]
14. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome. Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498 [Abstract] [Full Text] [Related]